Cleared Traditional

K130159 - QLAB QUANTIFICATION SOFTWARE HEART MODEL

K130159 is the FDA 510(k) clearance for QLAB QUANTIFICATION SOFTWARE HEART MODEL by Philips Health Care. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 110-day FDA review.

K130159 · Philips Health Care · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2013
Decision
110d
Days
Class 2
Risk

K130159 is an FDA 510(k) clearance for the QLAB QUANTIFICATION SOFTWARE HEART MODEL. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Philips Health Care (Andover, US). The FDA issued a Cleared decision on May 13, 2013 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Philips Health Care devices

Submission Details

510(k) Number K130159 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 2013
Decision Date May 13, 2013
Days to Decision 110 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 107d · This submission: 110d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K130159.
NIO COLOR 3MP LED
K131295 · Barco N.V. · May 2013
CORONIS 3MP
K131246 · Barco N.V. · May 2013
4D VIEW
K131118 · Ge Healthcare · May 2013
SYNAPSE 3D CARDIAC TOOLS
K130383 · Fujifilm Medical System U.S.A., Inc. · Apr 2013
INNOVA EPVISION 2.0, INNOVA EPVISION 2.0
K130069 · Ge Healthcare · Apr 2013
NOBELCLINICIAN
K123976 · Nobel Biocare AB · Mar 2013